(Q36135821)

12 August 2017

Phase I trial of elactocin (English)

1 reference

12 August 2017

phase I clinical trial

0 references

author name string

E S Newlands

series ordinal

1

1 reference

12 August 2017

G J Rustin

series ordinal

2

1 reference

12 August 2017

M H Brampton

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 1996

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

74

1 reference

12 August 2017

4

1 reference

12 August 2017

648-649

1 reference

Novel antitumor antibiotics, CI-940 (PD 114,720) and PD 114,721. Taxonomy, fermentation and biological activity.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074658

PubMed Central

reference URL

In vivo and in vitro anticancer activity of the structurally novel and highly potent antibiotic CI-940 and its hydroxy analog (PD 114,721).

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074658

PubMed Central

reference URL

Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues

2 July 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/8761384

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Novel antitumor antibiotics, CI-940 (PD 114,720) and PD 114,721. Taxonomy, fermentation and biological activity.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.38.460

Identifiers

DOI

10.1038/BJC.1996.415

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

8761384

1 reference